Top Markets
Coin of the day
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation

BGLC
株式のランク #18708
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on... BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
株価
$2.49
時価総額
$4.47M
変化(1日)
-4.01%
変化(1年)
678.16%
MY
取引 BioNexus Gene Lab Corporation (BGLC)

カテゴリー

BioNexus Gene Lab Corporation(BGLC)のP/S比率
March 2026 時点のP/S比率 TTM: 0.43
BioNexus Gene Lab Corporation の最新の財務報告および株価によると、現在のP/S比率(TTM)は 0.43 です。2023 年末時点でのP/S比率は 0.93 でした。
BioNexus Gene Lab Corporation の P/S 比率の履歴(2016 ~ 2026)
各年末時点のP/S比率
P/S比率 変化
2026 (TTM) 0.43 -18.23%
2024 0.52 -43.84%
2023 0.93 -93.79%
2022 15.03 -44.95%
2021 27.30 37.30%
2020 19.89 -98.67%
2019 1.50K 117.75%
2018 687.59 -54.92%
2017 1.53K 0.00%
2016 0.00 0.00%
同業他社のP/S比率
企業 P/S比率 P/S比率の差
3.87 810.56%
US
5.39 1,168.02%
US
10.65 2,403.93%
US
5.22 1,127.52%
CN
4.46 949.91%
US